PROCEPT BioRobotics Corporation
NASDAQ:PRCT
Overview | Financials
| Company Name | PROCEPT BioRobotics Corporation |
| Symbol | PRCT |
| Currency | USD |
| Price | 38.92 |
| Market Cap | 2,165,350,785 |
| Dividend Yield | 0% |
| 52-week-range | 37.12 - 103.81 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Dr. Reza Zadno Ph.D. |
| Website | https://www.procept-biorobotics.com |
An error occurred while fetching data.
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD







